Roseinatronobacter
Roseinatronobacter is a genus of bacteria in the family Rhodobacteraceae. The genus was first described in 2007, and currently includes two species: Roseinatronobacter monicus and Roseinatronobacter thiooxidans. These bacteria are known for their ability to oxidize sulfur compounds, a process that is important in the global sulfur cycle.
Taxonomy[edit | edit source]
The genus Roseinatronobacter belongs to the family Rhodobacteraceae, in the order Rhodobacterales, class Alphaproteobacteria, phylum Proteobacteria, and domain Bacteria. The genus was first described in 2007 by Sorokin et al., who isolated Roseinatronobacter monicus from a hypersaline lake in Mongolia. A second species, Roseinatronobacter thiooxidans, was described in 2010.
Characteristics[edit | edit source]
Roseinatronobacter species are Gram-negative, rod-shaped bacteria. They are facultatively anaerobic, meaning they can grow in both the presence and absence of oxygen. They are also halophilic, or salt-loving, and can grow in environments with high salt concentrations.
One of the key characteristics of Roseinatronobacter species is their ability to oxidize sulfur compounds. This process, known as sulfur oxidation, involves the conversion of sulfur compounds into sulfate. Sulfur oxidation is an important part of the global sulfur cycle, which plays a crucial role in the Earth's climate and the functioning of ecosystems.
Ecology[edit | edit source]
Roseinatronobacter species have been found in a variety of environments, including hypersaline lakes and sulfur springs. Their ability to oxidize sulfur compounds allows them to play a key role in these environments, where they contribute to the cycling of sulfur.
Medical relevance[edit | edit source]
While Roseinatronobacter species are not typically associated with human disease, their ability to oxidize sulfur compounds may have potential applications in bioremediation, the use of microorganisms to clean up environmental pollutants.
See also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD